Cargando…

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma is a common malignant cancer and the second most common cause of cancer-related deaths worldwide. Collagen triple helix repeat containing 1 (CTHRC1) has been increasingly reported to be involved in tumorigenesis and/or tumor progression. However, limited data are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huifang, Su, Libo, Liu, Chao, Li, Baosheng, Li, Hui, Xie, Ying, Sun, Dianxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765327/ https://www.ncbi.nlm.nih.gov/pubmed/31576140 http://dx.doi.org/10.2147/OTT.S219429

Ejemplares similares

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma
por: Wang, Yunpeng, et al.
Publicado: (2017)

CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer
por: Wang, Zejun, et al.
Publicado: (2022)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis
por: Chen, Yu-Ling, et al.
Publicado: (2013)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021)

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
por: Zhou, Fenfang, et al.
Publicado: (2021)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Cheng, Sheng, et al.
Publicado: (2023)

EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis
por: Gu, Fangming, et al.
Publicado: (2019)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

A distinctively expressed long noncoding RNA, RP11‐466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma
por: Zhang, Junyong, et al.
Publicado: (2018)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
por: Zhen, Jing, et al.
Publicado: (2023)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Peng, Qihang, et al.
Publicado: (2023)

AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer
por: Wu, Fanqi, et al.
Publicado: (2022)

CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma
por: Su, Qiuming, et al.
Publicado: (2022)

Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Ying, et al.
Publicado: (2023)

Application Potential of CTHRC1 as a Diagnostic and Prognostic Indicator for Colon Adenocarcinoma
por: Pang, Chen, et al.
Publicado: (2022)

The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker
por: Zhang, Xianwei, et al.
Publicado: (2018)

Conditional transcriptional relationships may serve as cancer prognostic markers
por: Yu, Hui, et al.
Publicado: (2021)

CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis
por: Myngbay, Askhat, et al.
Publicado: (2019)

Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma
por: Tao, Qi-fei, et al.
Publicado: (2015)

CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes
por: Sial, Nuzhat, et al.
Publicado: (2021)

Identification of key snoRNAs serves as biomarkers for hepatocellular carcinoma by bioinformatics methods
por: Xie, Qingqing, et al.
Publicado: (2022)

Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
por: Han, Ke‐qi, et al.
Publicado: (2016)

Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation
por: Lei, Jianyong, et al.
Publicado: (2017)

Focal adhesion kinase is overexpressed in thymic epithelial tumors and may serve as an independent prognostic biomarker
por: Li, Meng, et al.
Publicado: (2018)

CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2019)

The role of CTHRC1 in promotion of cutaneous wound healing
por: Duan, Xianlan, et al.
Publicado: (2022)

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014)

Leucine zipper downregulated in cancer 1 may serve as a favorable prognostic biomarker by influencing proliferation, colony formation, cell cycle, apoptosis, and migration ability in hepatocellular carcinoma
por: Chen, Huaping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bala2brm04jqcuhhh99s6v05sq